What is Tambocor, and who manufactures it?

Tambocor is a brand name for the antiarrhythmic medication flecainide acetate. It is used to treat irregular heartbeat (arrhythmia), particularly ventricular tachycardia and ventricular fibrillation.

Who makes Tambocor?

Tambocor is manufactured by Mylan, a global pharmaceutical company that has acquired several pharmaceutical companies, including a licensing agreement to produce Tambocor.

How long has Tambocor been in use?

Tambocor was first approved by the FDA in 1984 for the treatment of life-threatening ventricular arrhythmias.

What are the side effects of Tambocor?

According to the FDA-approved label, the most common side effects of Tambocor include dizziness, drowsiness, headache, and nausea.

Does Tambocor have any patent protection?

As per DrugPatentWatch.com [1], the Tambocor patent originally expired in 2010, and since then, the drug has been available in the market as a generic medication. However, it's worth noting that patent protection and generic market availability can change over time.

What are some alternatives to Tambocor?

Other medications used to treat arrhythmias, such as lidocaine and amiodarone, are alternatives to Tambocor. Additionally, patients may also consider biosimilar medications, which are similar to Tambocor but produced by different manufacturers at a lower cost.

Sources:

[1] DrugPatentWatch.com - Tambocor patent information